Pharmaceutical Department of the second hospital of Hebei Medical University, Shijiazhuang, PR China.
The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, PR China; The Key Laboratory of Pharmacology and Toxicology for New Drugs, Department of Pharmacology, Hebei Medical University, Shijiazhuang, PR China.
Biomed Pharmacother. 2014 Apr;68(3):267-75. doi: 10.1016/j.biopha.2013.12.003. Epub 2013 Dec 24.
Apoptosis of microvascular endothelial cells plays a crucial role in the progression of various lung diseases and triggers microcirculatory disorder and organ dysfunction. LPS, an outer membrane component of Gram-negative bacteria, is one of the major virulence factors for lung diseases. Recent studies have shown that the Rho/Rho kinase (ROCK) pathway plays an important role in the regulation of apoptosis, inflammatory cell migration and chemokine production in various cell types and animal models. We therefore undertake this study to investigate the inhibitory effect of fasudil, a potent and selective inhibitor of ROCK, on LPS-induced apoptosis of rat pulmonary microvascular endothelial cells (PMVECs). The results suggested that fasudil effectively prevented LPS-induced injury of rat PMVECs, as determined by MTT assay, LDH activity assay, apoptosis and western blot analysis of apoptosis-related proteins Bcl-2 and Bax. Furthermore, the mechanisms underlying the protective effect were evaluated. We found that LPS-induced MYPT-1 phosphorylation was markedly suppressed by fasudil. Moreover, fasudil pretreatment obviously inhibited the activation of JNK and p38 MAPKs induced by LPS, whereas that of ERK1/2 was not affected by fasudil. In addition, inhibiting the JNK and p38 pathways by SP600125 and SB203580 respectively attenuated the LPS-induced apoptosis and regulated the expression of apoptosis-related proteins Bcl-2 and Bax. Taken together, these results demonstrate that fasudil exerts an anti-apoptotic effect in rat PMVECs, which is mediated by the inhibition of Rho/ROCK and its downstream JNK and p38 MAPKs.
细胞凋亡在多种肺部疾病的进展中起着关键作用,并引发微循环障碍和器官功能障碍。脂多糖(LPS)是革兰氏阴性菌外膜的组成部分,是肺部疾病的主要毒力因子之一。最近的研究表明,Rho/Rho 激酶(ROCK)途径在各种细胞类型和动物模型中对细胞凋亡、炎症细胞迁移和趋化因子产生的调节中起着重要作用。因此,我们进行了这项研究,以探讨 ROCK 的强效和选择性抑制剂法舒地尔(fasudil)对 LPS 诱导的大鼠肺微血管内皮细胞(PMVECs)凋亡的抑制作用。结果表明,法舒地尔通过 MTT 测定、LDH 活性测定、凋亡测定和凋亡相关蛋白 Bcl-2 和 Bax 的 Western blot 分析,有效地防止了 LPS 诱导的大鼠 PMVEC 损伤。此外,还评估了保护作用的机制。我们发现,法舒地尔明显抑制了 LPS 诱导的 MYPT-1 磷酸化。此外,法舒地尔预处理明显抑制了 LPS 诱导的 JNK 和 p38 MAPKs 的激活,但对 ERK1/2 的激活没有影响。此外,分别用 SP600125 和 SB203580 抑制 JNK 和 p38 途径,减弱了 LPS 诱导的细胞凋亡,并调节了凋亡相关蛋白 Bcl-2 和 Bax 的表达。总之,这些结果表明,法舒地尔在大鼠 PMVECs 中发挥了抗凋亡作用,这是通过抑制 Rho/ROCK 及其下游 JNK 和 p38 MAPKs 介导的。